All News

By introducing TV and film writers to patients and experts in the cancer community, the Science & Entertainment Exchange is changing the stereotypical ‘hopeless story of cancer.’

Biological drugs, as well as animal testing, concern both consumers and researchers. But, as these drugs can save or extend lives, they provide important advances in medicine.

Upon meeting with my oncologist, I realized during our conversation about what was next for me, that he suddenly began to sound like a game show host.

Researchers worldwide believe low-dose light therapy may replace opioids in treating oral mucositis, a common side effect of certain cancer treatments.

The V Foundation announces multiple initiatives that contribute to ESPY Week fundraising success.

A two-time cancer survivor suggests what life after mid-life can be, even for cancer survivors.

After two years, the Biden Cancer Initiative has shuttered as former Vice President Joe Biden’s presidential campaign begins in earnest.

Those people who may seem like a burden while you navigate the new normal that is life with cancer may be the very people who support you through this journey. For the caregivers out there: try to maintain your autonomy.

Sometimes all we can do it put one foot in front of the other to keep going.

Patients with renal cell carcinoma who were treated with a targeted therapy lived three months longer than people who received older treatments.

The Hairy Cell Leukemia Foundation will host a free patient forum on July 17th with guest speaker Dr. Martin Tallman from Memorial Sloan Kettering Cancer Center. This forum is free and open to the public and will cover a range of issues related to patients’ journey with hairy cell leukemia.

The search for a clinical trial would turn out to be my most daunting mission yet as a patient with cancer. Here are five important lessons I've learned throughout my search.

CURE® asked its readers: “What is one thing you wish you could tell your younger, pre-cancer self?”

A cancerversary is a significant day of celebration for a person who has experienced cancer. Celebrating a cancerversary is a big deal, and one survivor hopes to provide some clarity on the situation.

The second recipe in our Summer Snacktime Series with the John Theurer Cancer Center works as a creative "meatless" meal or savory snack.

The use of Darzalex in combination with Revlimid, Velcade and Ozurdex demonstrated a higher percentage of stringent complete responses among transplant eligible, newly diagnosed patients with multiple myeloma.

The Food and Drug Administration granted CLR 131, a targeted, molecular radiotherapy, a fast track designation.

Breast cancer links to weight, diet and exercise are all over the news, but remember this: You are not to blame.

The Bladder Cancer Advocacy Network announced the recipient of its prestigious Bladder Cancer Research Innovation Award.

Don't sweat the small stuff, but don't miss those simple moments either.

An oncology dietitian offered advice on how to improve appetite and eat healthy before, during and after treatment for gastrointestinal cancers.

Moving on while letting go of being a 25-year-old caregiver back to being a young woman.

It is difficult to be patient, but cancer is a powerful teacher.

From today’s top performers and athletes to life-threatening social media disinformation, here’s what is making headlines in the cancer space this week.

This breast cancer survivor had a double mastectomy with reconstruction and reflects on the questions she wishes she'd asked the doctor, in hindsight.

Developing the skill of listening takes practice and for those with cancer, it's important to be heard. In this post, learn how one survivor helped others learn how to listen.

A quick scroll through the list of clinical trials made it clear I didn't know enough about my tumor and the mutations that made it unique.

The Food and Drug Administration has granted an accelerated approval to Xpovio in combination with dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma who have received more than four prior therapies.